These collective findings elucidate a multifaceted interplay between the ApoE genotype, gut microbiota, neuroinflammation, and AD pathology, consequently delineating potential therapeutic trajectories targeting microbiota-related mechanisms in AD. Here, APOE is linked to Alzheimer disease.